维普中文期刊产品整合服务
240篇 您的检索式:作者名="Ma HP"
    题名 作者 年代 出处 被引量
1Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy显示文摘Hepatitis due to hepatitis B virus(HBV) reactivation can be severe and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving cancer chemotherapy, especially rituximabcontaining therapy for hematological malignancies and those receiving stem cell transplantation. All patients with hematological malignancies receiving anticancer therapy should be screened for active or resolved HBV infection by blood tests for hepatitis B surface antigen(HBs Ag) and antibody to hepatitis B core antigen(antiHBc). Patients found to be positive for HBs Ag should be given prophylactic antiviral therapy to prevent HBV reactivation. For patients with resolved HBV infection, no standard strategy has yet been established to prevent HBV reactivation. There are usually two options. One is pre-emptive therapy guided by serial HBV DNA monitoring, whereby antiviral therapy is given as soon as HBV DNA becomes detectable. However, there is little evidence regarding the optimal interval and period of monitoring. An alternative approach is prophylactic antiviral therapy, especially for patients receiving highrisk therapy such as rituximab, newer generation of anti-CD20 monoclonal antibody, obinutuzumab or hematopoietic stem cell transplantation. This strategy may effectively prevent HBV reactivation and avoid the inconvenience of repeated HBV DNA monitoring. Entecavir or tenofovir are preferred over lamivudine as prophylactic therapy. Although there is no well-defined guideline on the optimal duration of prophylactic therapy, there is growing evidence to recommend continuing prophylactic antiviral therapy for at least 12 mo after cessation of chemotherapy, and even longer for those who receive rituximab or who had high serum HBV DNA levels before the start of immunosuppressive therapy. Many novel agents have recently become available for the treatment of hematological malignancies, and these agents may be associated with HBV reactivation. Although there is currently limited evidence to guide the optimal preventive measures, we recommend antiviral prophylaxis in HBs Ag-positive patients receiving novel treatments, especially the Bruton tyrosine kinase inhibitors and the phosphatidylinositol 3-kinase inhibitors, which are B-cell receptor signaling modulators and reduce proliferation of malignant B-cells. Further studies are needed to clarify the risk of HBV reactivation with these agents and the best prophylactic strategy in the era of targeted therapy for hematological malignancies.Man Fai Law Rita Ho Carmen KM Cheung Lydia HP Tam Karen Ma Kent CY So Bonaventure Ip Jacqueline So Jennifer Lai Joyce Ng Tommy HC Tam 2016World Journal of Gastroenterology2016,22,28:10
2Icariin, a flavonoid fr- om the herb Epimedium enhances the osteogenic differen- tiation of rat primary bone marrow stromal cells显示文摘Chen KM Ge BF Ma HP 2005Pharmazie2005,60,12:1
3Pharmacology of curcuma longa显示文摘Ammon HP Wahl MA 1991Planta Med1991,57,:1
4Neonatal meningitis: What is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebro- spinal fluid parameters? 显示文摘Garges HP Moody MA Cotten CM Smith PB Tiffany KF Len- festey R 2006J Pediatr2006,117,4:1
5Mechanical initiation of intervertebral disc degeneration显示文摘Adams MA Briaan JC Morrison HP 0,,:1
6Effect of aqueous extract of azadirachta indica leaves on hepatotoxicity induced by anti -tubercular drugs in rats显示文摘Kale BP Kothekar MA Tayade HP 2003Indian J Pharmaco12003,35,:1
7Ultraviolet A/riboflavin corneal cross-linking for infections keratitis associated with corneal melts显示文摘Iseli HP Thiel MA Hafezi F 2008Cornea2008,27,5:1
8Osthol, a coumarin isolated from common cnidium fruit, enhances the differentiation and maturation of osteoblasts in vitro显示文摘Ming LG Zhou J Cheng GZ Ma HP Chen KM 2011Pharmacology2011,88,12:1
9In vivo amyloid imaging inautopsy-confirmed Parkinson disease with dementia显示文摘Burack MA Hartlein J Flores HP 2010Neurology2010,74,1:1
10Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and eerebrospinal fluid parameter? 显示文摘Garges HP Moody MA Cotten CM 2006Pediatrics2006,117,4:1
11Antioxidant effect of red mould rice in hypercholesterolemic Wistar male rats 显示文摘Mohan-Kumari HP Dhale MA Akhilender Naidu K 2011Cell Biochem Funct2011,29,7:1
12Long-term follow-up of functional outcome in patients with a cloacal malformation: a systematic review显示文摘Versteegh HP van Rooij IA Levitt MA 2013J Pediatr Surg2013,48,11:1
13Mechanical initiation of intervertebral discdegeneration 显示文摘Adams MA Freeman B J Morrison HP 2000Spine ( Phila Pa 1976 )2000,25,:1
14Bounds on the local bases of primitive non-powerful minimally strong signed digraphs 显示文摘Ma HP 2009Linear Algebra Appl2009,430,:1
15Digital breast tomosynthesis: observer performance of clustered micro-calcification detection on breast phantom images ac- quired with an experimental system using variable scan angles, angular increments, and number of projection views显示文摘Ehan HP Goodsitt MM Helvie MA 2014Radiology2014,273,3:1
16Clinical guideline : management of gastroparesis显示文摘Camilleri M Parkman HP Shaft MA 2013Am J Gastroenterol2013,108,1:1
17Bounds on the local bases of primitive non-powerful, minimally strong signed digraphs 显示文摘Ma HP 2009Linear Algebra Appl2009,430,:1
18Mechanical initiation of intervertebral disc degeneration显示文摘Adams MA Freeman BJ Morrison HP 2000Spine2000,25,13:1
19Responses of normal cells to ionizing radiation显示文摘Rodemann HP Blaese MA 2007Semin Radiat Oncol2007,17,2:1
20Bounds on the local bases of primitive, non-powerful, minimally strong signed digraphs 显示文摘Ma HP 2009Linear Algebra Appl2009,430,:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费